For the year ending 2025-12-31, NOV had $322M increase in cash & cash equivalents over the period. $876M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 151 | 635 | 985 | 155 |
| Depreciation and amortization | 355 | 343 | 302 | 301 |
| Russia/belarus impairment and loss on assets held for sale | - | - | 4 | 127 |
| Goodwill and long-lived asset impairment | 70 | - | - | - |
| Deferred income taxes | 93 | 49 | -489 | -2 |
| Stock-based compensation | 67 | 70 | 66 | 67 |
| Equity (income) loss in unconsolidated affiliates | -16 | 36 | 119 | 68 |
| Dividend from unconsolidated affiliate | 2 | 84 | - | - |
| Gain on business divestiture | - | 130 | - | - |
| Provision for inventory losses | - | 31 | 28 | -18 |
| Other, net | -88 | -43 | 50 | -18 |
| Receivables | -222 | -93 | 269 | 440 |
| Inventories | -97 | -270 | 361 | 480 |
| Contract assets | 19 | -162 | 55 | 220 |
| Prepaid and other current assets | -41 | -17 | 40 | -6 |
| Accounts payable | -6 | -87 | -4 | 289 |
| Accrued liabilities | -48 | -51 | -116 | 101 |
| Contract liabilities | 73 | -42 | 82 | 52 |
| Income taxes payable | 39 | -5 | -6 | 5 |
| Other assets/liabilities, net | -10 | 142 | -185 | 72 |
| Net cash provided by operating activities | 1,251 | 1,304 | 143 | -179 |
| Purchases of property, plant and equipment | 375 | 351 | 283 | 214 |
| Business acquisitions, net of cash acquired | - | 298 | 22 | 49 |
| Business divestitures, net of cash disposed | - | 176 | - | - |
| Other, net | -13 | -2 | -12 | -25 |
| Net cash used in investing activities | -362 | -471 | -293 | -238 |
| Borrowings against lines of credit and other debt | 3 | 420 | 2 | 20 |
| Payments against lines of credit and other debt | 26 | 431 | 10 | 4 |
| Financing leases | 28 | 28 | 23 | 24 |
| Cash dividends paid | 190 | 108 | 79 | 78 |
| Share repurchases | 315 | 229 | - | - |
| Other | -28 | -30 | 7 | -10 |
| Net cash used in financing activities | -584 | -406 | -103 | -96 |
| Effect of exchange rates on cash | 17 | -13 | - | -9 |
| Increase (decrease) in cash and cash equivalents | 322 | 414 | -253 | -522 |
| Cash and cash equivalents at beginning of period | 1,230 | 816 | 1,069 | 1,591 |
| Cash and cash equivalents at end of period | 1,552 | 1,230 | 816 | 1,069 |
NOV Inc. (NOV)
NOV Inc. (NOV)